These findings suggest that gypenoside induces apoptosis through PI3K/AKT/mTOR inhibition and boosts T‐cell‐mediated immunity by suppressing STAT3 phosphorylation and PD‐L1 expression, making it a promising candidate for gastric cancer immunotherapy. The gene discussed is AKT1; the disease is gastric cancer.